- Home
- PEN vs RVTY Comparison
PEN vs RVTY Comparison
Compare PEN & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEN
- RVTY
- Stock Information
- Founded
- PEN 2004
- RVTY 1937
- Country
- PEN United States
- RVTY United States
- Employees
- PEN N/A
- RVTY N/A
- Industry
- PEN Medical/Dental Instruments
- RVTY Biotechnology: Laboratory Analytical Instruments
- Sector
- PEN Health Care
- RVTY Industrials
- Exchange
- PEN Nasdaq
- RVTY Nasdaq
- Market Cap
- PEN 10.5B
- RVTY 11.6B
- IPO Year
- PEN 2015
- RVTY N/A
- Fundamental
- Price
- PEN $277.35
- RVTY $91.82
- Analyst Decision
- PEN Strong Buy
- RVTY Buy
- Analyst Count
- PEN 16
- RVTY 11
- Target Price
- PEN $290.93
- RVTY $132.45
- AVG Volume (30 Days)
- PEN 451.5K
- RVTY 1.3M
- Earning Date
- PEN 04-23-2025
- RVTY 04-28-2025
- Dividend Yield
- PEN N/A
- RVTY 0.29%
- EPS Growth
- PEN N/A
- RVTY N/A
- EPS
- PEN 0.36
- RVTY 2.20
- Revenue
- PEN $1,194,615,000.00
- RVTY $2,755,026,000.00
- Revenue This Year
- PEN $14.26
- RVTY $4.79
- Revenue Next Year
- PEN $14.21
- RVTY $6.13
- P/E Ratio
- PEN $762.38
- RVTY $39.92
- Revenue Growth
- PEN 12.86
- RVTY 0.16
- 52 Week Low
- PEN $148.00
- RVTY $89.61
- 52 Week High
- PEN $310.00
- RVTY $129.50
- Technical
- Relative Strength Index (RSI)
- PEN 53.70
- RVTY 36.30
- Support Level
- PEN $253.27
- RVTY $89.61
- Resistance Level
- PEN $278.39
- RVTY $97.98
- Average True Range (ATR)
- PEN 14.09
- RVTY 5.36
- MACD
- PEN 0.97
- RVTY -0.41
- Stochastic Oscillator
- PEN 90.04
- RVTY 12.59
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.
About RVTY Revvity Inc.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.